Search
Akebia Therapeutics Inc
AKBAAdd to Watchlist
0.963USD
+0.011+1.16%
Close 09-14 16:00（ET）
261.69MMarket Cap
LossP/E TTM
TradingKey Chart
Intraday
1m
30m
1h
D
W
M
D
Today
+1.16%
5 Days
-1.23%
1 Month
+10.69%
6 Months
-34.04%
Year to Date
-40.19%
1 Year
-67.36%
Key Figures
0.952Open
1.015High
464.10KVolume
LossP/E TTM
LossP/E Dynamic
--Dividend TTM
0.17%Turnover Ratio
0.952Prev. Close
0.904Low
452.68KTurnover
LossP/E Static
10.46P/B
0.00%Div Yield TTM
-6.10%ROA
3.20052wk High
33.10Volume Ratio
-69.41MNet Profit
271.74MShares
-0.0806EPS TTM
0.28Beta
-78.96%ROE
0.81452wk Low
11.66%Amplitude
81.13%Gross Margin
261.69MMarket Cap
-8.72Reward/Risk
4.91%Risk Rate
Akebia Therapeutics Inc's Score
-0.23vs previous score
Forecast9.20
Financial Health7.71
Technical4.53
Valuation Dimensions8.81
Institutional Confidence3.00
Risk Assessment3.98
Media Coverage
Coverage Level
Very Low
Very High
Neutral
Analyst Rating
Akebia Therapeutics Inc Technical Analysis
Technical Indicators
Neutral
Summary
Sell
Moving Average
Strong sell
Financial Indicators
Relevant data have not been disclosed by the company yet.
Relevant data have not been disclosed by the company yet.
Earnings
Next reporting date
--
Reporting Period
2026Q2
Earnings / Forecast
-0.03/-0.04
Revenue / Forecast
49.13M/48.86M
Akebia Therapeutics Inc Profile
SectorPharmaceuticals
Ticker SymbolAKBA
Number of employees181
CountryUnited States of America
Ownership
| Shareholders | Proportion |
|---|---|
| BlackRock Institutional Trust Company, N.A. | 6.49% |
| State Street Investment Management (US) | 4.33% |
| Vanguard Capital Management, LLC | 4.16% |
| Geode Capital Management, L.L.C. | 2.34% |
| Shareholder Types | Proportion |
|---|---|
| Investment Advisor | 19.09% |
| Investment Advisor/Hedge Fund | 14.33% |
| Hedge Fund | 5.92% |
| Research Firm | 4.42% |
Related Instruments
+2.02%
+0.28%
+2.25%
+1.81%
+0.64%
+1.33%
+1.10%
+1.87%
0.00%
+0.88%
+0.79%
+0.72%
+3.34%
+1.31%
+3.99%
+1.57%
+0.62%
+1.86%
+1.89%
+0.14%
FAQs
What is the current price of Akebia Therapeutics Inc (AKBA)?
The current price of Akebia Therapeutics Inc (AKBA) is 0.95.
What is the symbol of Akebia Therapeutics Inc?
The ticker symbol of Akebia Therapeutics Inc is AKBA.
What is the 52-week high of Akebia Therapeutics Inc?
The 52-week high of Akebia Therapeutics Inc is 3.20.
What is the 52-week low of Akebia Therapeutics Inc?
The 52-week low of Akebia Therapeutics Inc is 0.81.
What is the market capitalization of Akebia Therapeutics Inc?
The market capitalization of Akebia Therapeutics Inc is 259.24M.
Is Akebia Therapeutics Inc (AKBA) currently rated as Buy, Hold, or Sell?
According to analysts, Akebia Therapeutics Inc (AKBA) has an overall rating of Buy, with a price target of 3.92.
What is the Earnings Per Share (EPS TTM) of Akebia Therapeutics Inc (AKBA)?
The Earnings Per Share (EPS TTM) of Akebia Therapeutics Inc (AKBA) is -0.08.